Who owns LIFECORE BIOMEDICAL, INC. \DE\ (LCBM)? Elite investor 13F holders

5 tracked elite investors reported holding LIFECORE BIOMEDICAL, INC. \DE\ as of 2026-06-30, including Wynnefield Capital, Legion Partners, 22NW Fund, Renaissance Technologies LLC, GAMCO. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Wynnefield CapitalLandec Corp.SHARE2026-06-302026-08-14 00:00:0024691884.00 USD4703216.000000SharesholdOriginal filing
Legion PartnersLandec Corp.SHARE2026-06-302026-08-14 00:00:0023424571.00 USD4461823.000000SharesholdOriginal filing
22NW FundLandec Corp.SHARE2026-06-302026-08-14 00:00:006220.00 USD1254.000000SharesholdOriginal filing
Renaissance Technologies LLCLandec Corp.SHARE2026-06-302026-08-13 00:00:00550510.00 USD104859.000000SharesbuyOriginal filing
GAMCOLandec Corp.SHARE2026-06-302026-08-12 00:00:00439950.00 USD83800.000000SharesholdOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown